Full-Time
Develops RNA-based medicines and therapies
No salary listed
Expert
Cambridge, MA, USA
Get referrals →
You have ways to get a Orbital Therapeutics referral from your network.
Applications through a referral are 3x more likely to get an interview!
Upload your resume to see how it matches 2 keywords from the job description.
PDF, DOC, DOCX, up to 4 MB
Orbital Therapeutics focuses on developing RNA-based medicines, specifically targeting areas like vaccines, immunomodulation, and protein replacement. The company utilizes RNA technology, advanced delivery methods, data science, and automation to create a platform for a wide range of therapeutic applications. Unlike many competitors, Orbital Therapeutics does not work with small interfering RNA, allowing it to carve out a unique niche in the genetic medicine space. The goal is to enhance global health by harnessing RNA medicines to treat diseases in innovative ways. Revenue is generated through the sale of these therapies to healthcare providers, who then administer them to patients.
Company Size
51-200
Company Stage
Series A
Total Funding
$270M
Headquarters
San Francisco, California
Founded
2022
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Orbital Therapeutics appoints Geno Germano, biopharma veteran, to its Board of Directors.
Orbital Therapeutics appoints Anna Dixon as senior vice president, human resources.
Orbital Therapeutics appoints veteran biopharma leader, Ron Philip, as chief executive officer.
Orbital Therapeutics, a company focused on enhancing global health by unleashing the full potential of RNA medicines to treat human disease, today ann
Orbital Therapeutics aims to develop RNA-based therapeutics for various human diseases, including next-generation vaccines, immunomodulation, and protein replacement.